Ginkgo Bioworks Holdings Inc (DNA) stock is down -63.96% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives DNA stock a score of 35 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 1. DNA’s rank also includes a long-term technical score of 10.
What’s Happening with DNA Stock Today
Ginkgo Bioworks Holdings Inc (DNA) stock has risen 2.14% while the S&P 500 is down -0.31% as of 11:13 AM on Tuesday, Jan 17. DNA is higher by $0.04 from the previous closing price of $1.87 on volume of 8,139,850 shares. Over the past year the S&P 500 has fallen -12.90% while DNA is down -63.96%. DNA lost -$2.23 per share in the over the last 12 months.
Click Here to get the full Stock Report for Ginkgo Bioworks Holdings Inc stock.
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
I have been writing professionally for over 20 years and have a deep understanding of the psychological and emotional elements that affect people. I’m an experienced ghostwriter and editor, as well as an award-winning author of five novels.